Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigenNAGATA, A; HIROTA, N; SAKAI, T et al.Tumor biology. 1991, Vol 12, Num 5, pp 279-286, issn 1010-4283Article

Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary reportKAFALI, Hasan; ARTUC, Hülya; DEMIR, Nurettin et al.European journal of obstetrics, gynecology, and reproductive biology. 2004, Vol 116, Num 1, pp 85-88, issn 0301-2115, 4 p.Article

Bichemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsiaDE GROOT, C. J. M; O'BRIEN, T. J; TAYLOR, R. N et al.American journal of obstetrics and gynecology. 1996, Vol 175, Num 1, pp 24-29, issn 0002-9378Article

Predictive value of CA 125 in patients with epithelial ovarian cancer undergoing second-look laparotomyO'CONNELL, G. J; RYAN, E; MURPHY, K. J et al.Journal of tumor marker oncology. 1987, Vol 1, Num 4, pp 243-247, issn 0886-3849Article

Ovarian Cancer: Biomarker Proteomic Diagnosis in ProgressYONG ZHANG; BIN GUO; RAN BI et al.Applied biochemistry and biotechnology. 2012, Vol 168, Num 4, pp 910-916, issn 0273-2289, 7 p.Article

Peritoneal Membrane Evaluation in Routine Clinical PracticeRODRIGUES, Anabela S; SILVA, Sandra; BRAVO, Fernanda et al.Blood purification. 2007, Vol 25, Num 5-6, pp 497-504, issn 0253-5068, 8 p.Article

Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapyVAN DER BURG, M. E. L; LAMMES, F. B; VAN PUTTEN, W. L. J et al.Gynecologic oncology (Print). 1988, Vol 30, Num 3, pp 307-312, issn 0090-8258Article

Intra-peritoneal CA125: a potential tumour markerREDMAN, C. W. E; LAWTON, F. G; LEWIS, P et al.Journal of tumor marker oncology. 1988, Vol 3, Num 1, pp 45-47, issn 0886-3849Article

Marqueurs sériques et tumoraux ovariens dans le diagnostic des tumeurs ovariennes présumées bénignes = Ovarian tumor markers of presumed benign ovarian tumorsLAHLOU, N; BRUN, J.-L.Journal de gynécologie obstétrique et biologie de la reproduction. 2013, Vol 42, Num 8, pp 752-759, issn 0368-2315, 8 p.Article

HE4 and ROMA Index in Czech Postmenopausal WomenNOVOTNY, Zdenek; PRESL, Jiri; KUCERA, Radek et al.Anticancer research. 2012, Vol 32, Num 9, pp 4137-4140, issn 0250-7005, 4 p.Article

Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colonSTREPPEL, Mirte M; VINCENT, Audrey; MUKHERJEE, Radha et al.Human pathology. 2012, Vol 43, Num 10, pp 1755-1763, issn 0046-8177, 9 p.Article

Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcomeZANOTTI, Laura; BIGNOTTI, Eliana; CAIMI, Luigi et al.Clinical chemistry and laboratory medicine. 2012, Vol 50, Num 12, pp 2189-2198, issn 1434-6621, 10 p.Article

Emergence of CA125 Immunoreactivity in Recurrent or Metastatic Primary Ovarian Mucinous Neoplasms of the Intestinal TypeMILLER, Keith; MILLAR, Joanne; MCCLUGGAGE, W. Glenn et al.The American journal of surgical pathology. 2011, Vol 35, Num 9, pp 1331-1336, issn 0147-5185, 6 p.Article

The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian massesLENHARD, Miriam; STIEBER, Petra; HERTLEIN, Linda et al.Clinical chemistry and laboratory medicine. 2011, Vol 49, Num 12, pp 2081-2088, issn 1434-6621, 8 p.Article

Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapyHAN, Liz Y; KARAVASILIS, Vasilios; KAYE, Stan B et al.European journal of cancer (1990). 2010, Vol 46, Num 8, pp 1359-1364, issn 0959-8049, 6 p.Article

HE4, un nouveau marqueur des cancers épithéliaux ovariens: évaluation des performances analytiques = HE4, a novel marker for epithelial ovarian cancer: evaluation of analytical performancesLAMY, Pierre-Jean; ROQUES, Sylvie; VIGLIANTI, Cathy et al.Annales de biologie clinique (Paris). 2010, Vol 68, Num 3, pp 325-329, issn 0003-3898, 5 p.Article

Lack of Reliability of CA125 Response Criteria With Anti-VEGF Molecularly Targeted TherapyAZAD, Nilofer S; ANNUNZIATA, Christina M; STEINBERG, Seth M et al.Cancer. 2008, Vol 112, Num 8, pp 1726-1732, issn 0008-543X, 7 p.Article

Mesothelin-related predictive and prognostic factors in malignant mesothelioma : A nested case-control studyROE, Oluf Dimitri; CREANEY, Jenette; LUNDGREN, Steinar et al.Lung cancer. 2008, Vol 61, Num 2, pp 235-243, issn 0169-5002, 9 p.Article

THE CLINICAL USEFULNESS OF PERITONEAL DIALYSIS FLUIDS WITH NEUTRAL pH AND LOW GLUCOSE DEGRADATION PRODUCT CONCENTRATION : AN OPEN RANDOMIZED PROSPECTIVE TRIALHOON YOUNG CHOI; DONG KI KIM; HAN, Dae-Suk et al.Peritoneal dialysis international. 2008, Vol 28, Num 2, pp 174-182, issn 0896-8608, 9 p.Article

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125CANNEY, P. A; WILKINSON, P. M; JAMES, R. D et al.British journal of cancer. 1985, Vol 52, Num 1, pp 131-133, issn 0007-0920Article

A 2-Stage Ovarian Cancer Screening Strategy Using the Risk of Ovarian Cancer Algorithm (ROCA) Identifies Early-Stage Incident Cancers and Demonstrates High Positive Predictive ValueLU, Karen H; SKATES, Steven; ADEYINKA, Olasunkanmi et al.Cancer. 2013, Vol 119, Num 19, pp 3454-3461, issn 0008-543X, 8 p.Article

Stratégies diagnostiques des tumeurs ovariennes présumées bénignes = Diagnosis of presumed benign ovarian tumorsLACULLE-MASSIN, C; COLLINET, P; FAYE, N et al.Journal de gynécologie obstétrique et biologie de la reproduction. 2013, Vol 42, Num 8, pp 760-773, issn 0368-2315, 14 p.Article

Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancerPARK, Yongjung; KIM, Yoonjung; EUN YOUNG LEE et al.International journal of cancer (Print). 2012, Vol 130, Num 5, pp 1136-1144, issn 0020-7136, 9 p.Article

How Are Symptoms of Ovarian Cancer Managed?: A Study of Primary Care PhysiciansGOFF, Barbara A; MATTHEWS, Barbara; ANDRILLA, C. Holly A et al.Cancer. 2011, Vol 117, Num 19, pp 4414-4423, issn 0008-543X, 10 p.Article

The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?MONTAGNANA, Martina; DANESE, Elisa; RUZZENENTE, Orazio et al.Clinical chemistry and laboratory medicine. 2011, Vol 49, Num 3, pp 521-525, issn 1434-6621, 5 p.Article